Dentists Have a Unique Investment Position. The Question Is: Do We Use It?

‍

A dentist lives in the reality of the profession every single day.
He sees what works. He feels what doesn’t. He immediately notices whether something improves workflow — or slows it down.

In reality, a dentist performs due diligence every day.

• Materials
• Workflow
• Chair time
• Patient acceptance
• Compliance‍

Often, he knows faster than anyone whether a product will end up forgotten in a cabinet — or become a habit. And that is exactly where the strength lies.

‍

Success Is not in the Promise. It Is in the Habit

A product can be technologically impressive. But if it does not fit the practice, it will never succeed.

Success happens when something becomes a habit. When a dentist integrates it naturally into daily work.

And that is precisely what we, as dentists, can assess better than anyone else.

‍

Yet We Rarely Enter Early

And that is where it becomes uncomfortable.

When dentists discover a strong product, it is often already late.
Not too late to use it. But too late to benefit from the real growth.

Dentists are often called “late adopters.”
Not because they are not intelligent.
But because they are busy. The agenda is full. The work is physically and mentally demanding.

And on top of that: we are rarely invited to participate early.

But perhaps we should also ask ourselves honestly:
Do we make ourselves available?

‍

An IPO Is not Early Stage

Many people believe they are early when a company goes public. But by that moment, venture capitalists have often been invested for years. Their strategy is simple: enter early and exit once the value is proven.

That exit may come through a sale to a larger player. Or through an IPO. At an IPO, smaller investors often buy out early investors — frequently at significant gains.

The real value creation happens before that.

‍

An Example Worth Reflecting On

Let’s make it concrete.

In 2001, you could invest €10,000 in a pre-IPO round of Align Technology.
Had you done so, that amount would have grown to approximately €3.8 million by 2024.

That is not a typical return. That is 380x growth.

Returns like that do not merely improve a portfolio.
They change a life. A legacy.

Dentists understood years before the broader market what clear aligners meant for orthodontics. They saw the adoption. They experienced the shift in their own practices.

But most remained spectators.

They used the product.
They believed in the technology.
But they did not invest.

That missed momentum is not an exception. It reflects a structural pattern. And it is repeating itself today.

‍

Europe Has the Talent. But the Capital Leaves

In Europe, especially in the dental sector, we have strong technology. Creative. High quality. Yet many promising companies move to the United States once they want to scale.

Why? Because that is where capital is willing to take risk.

The word “risk” makes us uncomfortable.
It does not fit the traditional profile of a healthcare provider.

But what if that risk becomes manageable when shared?

‍

Angel Clinicians: Stronger Together Than Individually

Angel Clinicians starts from one simple thought: If dentists perform clinical due diligence every day, why not pool that knowledge?

When a large group of dentists tests a product and there is no real enthusiasm, we do not proceed.

When there is conviction, we know it is supported by people who will actually use it.

That is fundamentally different from traditional investment models.
A classic VC can analyse numbers. But he does not feel the practice.

We do.

And when capital comes from future users, a company stands stronger from day one.
You do not just create investors. You create ambassadors.

‍

What Does This Mean in Practice?

Companies are thoroughly screened first. Legally. Financially. Strategically.

We only present what we ourselves take seriously.

Members of Angel Clinicians gain access to that first line.
Not to invest blindly — but to decide based on substance.

We work together toward an exit. Sometimes fast. Sometimes over several years. It depends on the trajectory. In case of success, we take a success fee.

That seems fair.

If it works for you, it works for us.